Cuba vs Palestine, State of: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Cuba
99.0%
in 2025
Palestine, State of
99.0%
in 2025
Cuba rank
1st
Palestine, State of rank
1st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Cuba
- Palestine, State of
How they compare
Cuba currently reports 99.0% against 99.0% in Palestine, State of, a difference of 0.0%.
Across all 18 years both countries report, Palestine, State of has been ahead every year.
Cuba ranks 1st and Palestine, State of ranks 1st of 194 countries.
Palestine, State of has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | Palestine, State of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 71.3% | 71.3% | Palestine, State of |
| 2020s | 16.5% | 96.2% | 79.7% | Palestine, State of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Cuba or Palestine, State of?
- Cuba, at 99.0% against 99.0% in Palestine, State of as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Cuba and Palestine, State of?
- 0.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Palestine, State of?
- 18 years are reported by both, from 2008 to 2025.
- How do Cuba and Palestine, State of rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cuba ranks 1st and Palestine, State of ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.